Most providers recommend 7 to 10 days (washout strategy) to minimize overlapping side effects
The long-term data on standard-dose GLP-1 medications continues to be reassuring most cardiovascular and renal outcome trials now extend out 3 to 5 years
None occurred significantly more often with MT-II compared to placebo [7, 14]
Together, we can determine the best personalized approach for your health, carefully considering potential benefits, risks, and overall suitability
Int J Biol Macromol
Low-density lipoprotein (LDL), often called bad cholesterol, levels, specifically apolipoprotein B (apoB), are crucial indicators of cardiovascular risk, and high LDL levels combined with general inflammation can further elevate risk